These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 16814761
1. Postprandial behavior of plasma squalene and non-cholesterol sterols in men with varying cholesterol absorption. Hallikainen M, Vidgren H, Agren JJ, Kiviniemi V, Miettinen TA, Gylling H. Clin Chim Acta; 2006 Dec; 374(1-2):63-8. PubMed ID: 16814761 [Abstract] [Full Text] [Related]
2. Twenty-one year tracking of serum non-cholesterol sterols. The Cardiovascular Risk in Young Finns study. Miettinen TA, Hallikainen M, Raitakari OT, Viikari J, Gylling H. Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):525-31. PubMed ID: 19185477 [Abstract] [Full Text] [Related]
3. Applicability of non-cholesterol sterols in predicting response in cholesterol metabolism to simvastatin and fluvastatin treatment among hypercholesterolemic men. Nissinen MJ, Miettinen TE, Gylling H, Miettinen TA. Nutr Metab Cardiovasc Dis; 2010 Jun; 20(5):308-16. PubMed ID: 19695854 [Abstract] [Full Text] [Related]
4. Serum noncholesterol sterols in children with heterozygous familial hypercholesterolemia undergoing pravastatin therapy. Hedman M, Miettinen TA, Gylling H, Ketomäki A, Antikainen M. J Pediatr; 2006 Feb; 148(2):241-6. PubMed ID: 16492436 [Abstract] [Full Text] [Related]
5. Cholesterol absorption and synthesis in children with type 1 diabetes. Järvisalo M, Raitakari O, Gylling H, Miettinen TA. Diabetes Care; 2006 Oct; 29(10):2300-4. PubMed ID: 17003310 [Abstract] [Full Text] [Related]
6. The validity of serum squalene and non-cholesterol sterols as surrogate markers of cholesterol synthesis and absorption in type 2 diabetes. Simonen P, Gylling H, Miettinen TA. Atherosclerosis; 2008 Apr; 197(2):883-8. PubMed ID: 17875306 [Abstract] [Full Text] [Related]
7. Responses of surrogate markers of cholesterol absorption and synthesis to changes in cholesterol metabolism during various amounts of fat and cholesterol feeding among healthy men. Nissinen MJ, Gylling H, Miettinen TA. Br J Nutr; 2008 Feb; 99(2):370-8. PubMed ID: 17697430 [Abstract] [Full Text] [Related]
8. Markers of absorption and synthesis of cholesterol in men with type 1 diabetes. Gylling H, Laaksonen DE, Atalay M, Hallikainen M, Niskanen L, Miettinen TA. Diabetes Metab Res Rev; 2007 Jul; 23(5):372-7. PubMed ID: 17080398 [Abstract] [Full Text] [Related]
9. Synthesis and absorption of cholesterol in Finnish boys by serum non-cholesterol sterols: the cardiovascular risk in Young Finns Study. Miettinen TA, Gylling H, Viikari J, Lehtimäki T, Raitakari OT. Atherosclerosis; 2008 Sep; 200(1):177-83. PubMed ID: 18178213 [Abstract] [Full Text] [Related]
10. Serum adipokines are associated with cholesterol metabolism in the metabolic syndrome. Hallikainen M, Kolehmainen M, Schwab U, Laaksonen DE, Niskanen L, Rauramaa R, Pihlajamäki J, Uusitupa M, Miettinen TA, Gylling H. Clin Chim Acta; 2007 Aug; 383(1-2):126-32. PubMed ID: 17573060 [Abstract] [Full Text] [Related]
11. The distribution of squalene and non-cholesterol sterols in lipoproteins in type 2 diabetes. Simonen PP, Gylling H, Miettinen TA. Atherosclerosis; 2007 Sep; 194(1):222-9. PubMed ID: 16963050 [Abstract] [Full Text] [Related]
12. Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway. van Himbergen TM, Otokozawa S, Matthan NR, Schaefer EJ, Buchsbaum A, Ai M, van Tits LJ, de Graaf J, Stalenhoef AF. Arterioscler Thromb Vasc Biol; 2010 Jan; 30(1):113-20. PubMed ID: 19834104 [Abstract] [Full Text] [Related]
13. Serum cholestanol, cholesterol precursors, and plant sterols during placebo-controlled treatment of primary biliary cirrhosis with ursodeoxycholic acid or colchicine. Miettinen TA, Färkkilä M, Vuoristo M, Karvonen AL, Leino R, Lehtola J, Friman C, Seppälä K, Tuominen J. Hepatology; 1995 May; 21(5):1261-8. PubMed ID: 7737632 [Abstract] [Full Text] [Related]
14. Postprandial lipemic response and lipoprotein composition in subjects with low or high cholesterol absorption efficiency. Agren JJ, Hallikainen M, Vidgren H, Miettinen TA, Gylling H. Clin Chim Acta; 2006 Apr; 366(1-2):309-15. PubMed ID: 16364276 [Abstract] [Full Text] [Related]
15. Patterns of cholesterol metabolism: pathophysiological and therapeutic implications for dyslipidemias and the metabolic syndrome. Lupattelli G, De Vuono S, Mannarino E. Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):620-7. PubMed ID: 21855307 [Abstract] [Full Text] [Related]
16. Effect of dalcetrapib, a CETP modulator, on non-cholesterol sterol markers of cholesterol homeostasis in healthy subjects. Niesor EJ, Chaput E, Staempfli A, Blum D, Derks M, Kallend D. Atherosclerosis; 2011 Dec; 219(2):761-7. PubMed ID: 21982411 [Abstract] [Full Text] [Related]
17. Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome. Ooi EM, Watts GF, Barrett PH, Chan DC, Clifton PM, Ji J, Nestel PJ. Asia Pac J Clin Nutr; 2007 Dec; 16(4):624-31. PubMed ID: 18042521 [Abstract] [Full Text] [Related]
18. Removal of intravenous Intralipid in patients with familial hypercholesterolemia during inhibition of cholesterol absorption and synthesis. Ketomäki A, Gylling H, Miettinen TA. Clin Chim Acta; 2004 Jun; 344(1-2):83-93. PubMed ID: 15149875 [Abstract] [Full Text] [Related]
19. Effects of plant stanol esters supplied in a fat free milieu by pastilles on cholesterol metabolism in colectomized human subjects. Nissinen MJ, Gylling H, Miettinen TA. Nutr Metab Cardiovasc Dis; 2006 Sep; 16(6):426-35. PubMed ID: 16935701 [Abstract] [Full Text] [Related]